Clinical Trials
3 trialsNCT06641089 2026-06-12
IZAR-2
MoonLake Immunotherapeutics AG
Phase 3 Recruiting
NCT03816345 2026-06-11
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
Phase 1 Recruiting
NCT04751396 2026-05-20
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
M.D. Anderson Cancer Center
Recruiting